alias:: DR
ICD-11_Code:: 9B71
tags:: disease, diabetes, opthalmology

- #definition Diabetic Retinopathy is a diabetes related eye disease that affects the blood vessels in the retina, leading to vision impairment and potential blindness if untreated
- ## Etiology
  background-color:: blue
	- ### Causative Agents
		- Chronic Hyperglycemia (high blood sugar)
		- Insulin Resistance
	- ### Risk Factors
		- Long Duration of Diabetes (>10 years)
		- Poor Glycemic control (high HbA1c)
		- Hypertension
		- Pregnancy (gestational diabetes)
		- Smoking
		- Genetic Predisposition
- ## Epidemiology
  background-color:: blue
	- ### Incidence
		- ~30% of diabetics develop DR after 30 years
		- ~80% after 20 years
	- ### Prevalence
		- Leading cause of blindness in working-age adults
		- ### Demographics
			- Higher in Type 1 vs. Type 2 diabetes
			- More severe in younger patients with poor control
	- ### Geographic Distribution
		- Higher in low/middle-income countries due to limited screening
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
		- Microvascular damage due to hyperglycemia -> retinal ischemia -> VEGF release -> neovascularization
		- Breakdown of blood retinal barrier -> edema, hemorrhage
	- ### Affected Systems/Organs
		- Retina (especially macula)
		- Vitreous (in proliferative stage)
- ## Clinical Features
  background-color:: blue
	- ### Clinical Presentation
		- #### Symptoms
			- Blurred Vision
			- Floaters
			- Sudden vision loss (if vitreous hemorrhage)
		- #### Signs
			- Retinal hemorrhages
			- Cotton wool spots
			- Macular edema
	- ### Stages or Classification
		- Non-proliferative Diabetic Retinopathy
			- Clinical Features
				- Microaneurysm
				- Dot & Blot Hemorrhage
				- Flame shaped hemorrhage
				- Hard exudate
				- Retinal edema
			- Stages/Classificaition
				- |stage|S/S|
				  |--|--|
				  |Mild NPDR|microaneurysms only|
				  |Moderate NPDR|more hemorrhages, venous beading|
				  |Severe NPDR | 4-2-1 rule : hemorrhages in 4 quadrants, venous beading in 2, IRMA in 1|
				  |Very Severe NPDR| widespread abnormalities|
		- Proliferative Phase
			- Clinical Features
				- Neovascularisation
				- Vitreous Hemorrhage
				- Retinal Detachment
			- Stages/Classification
				- |stage|S/S|
				  |--|--|
				  |Early PDR|Neovascularization without complications|
				  |High risk PDR|Neovascularization + vitreous hemorrhage|
				  |Advanced Diabetic Eye Disease|Traction Retinal Detachment|
		- Diabetic Maculopathy
			- |stage|S/S|
			  |--|--|
			  |Focal| Localized leakage|
			  |Diffuse|Widespread edema|
			  |Ischemic| capillary non-perfusion|
- ## Diagnosis
  background-color:: blue
	- ### Diagnostic Criteria
		- Fundoscopic exam + imaging
	- ### Investigation
		- ### Establishing Diagnosis
			- Dilated fundus exam
			- Optical Coherence Tomograpy (OCT)
			- Fluorescein angiography
		- ### Ruling Out Differential Diagnosis
			- |DD|Ruling Out|
			  |--|--|
			  |Hypertensive Retinopathy|BP history, absence of neovascularization|
			  |Retinal Vein Occlusion| Unilateral, sectoral hemorrhages|
			  |Macular Degeneration| Drusen, older age group|
		- ### General Assessment
			- HbA1c
			- Lipid Profile
			- Renal Function
- ## Management and Treatment
  background-color:: blue
	- ### Medical Treatment
		- Intraocular Anti-VEGF Injections (Ranibizumab, Afibercept)
		- Steroids (Intravitreal implants)
	- ### Surgical Options
		- Laser photocoagulation (panretinal or focal)
		- Vitrectomy (for vitreous hemorrhage/tractional detachment)
	- ### Lifestyle and Dietary Recommendations
		- Tight glycemic control (HbA1c <7%)
		- Blood Pressure Management (<130/80 mmHg)
		- Smoking cessation
	- ### Follow-up
		- Annual screening for diabetics
		- More frequent if DR present
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment : Stabilization/Improvement in ~90%
		- #### Without Treatment
			- ##### Possible Complications
				- Blindness, Retinal Detachment
			- ##### Long-Term Effects
				- Permanent Vision Loss
	- ### Survival Rates
		- #### With Treatment
			- Vision Preservation >80% with early intervention
			- Poor if untreated (50% severe vision loss in PDR)
		- #### Without Treatment
	- ### Quality of Life Considerations
		- Reduced independence if advanced
- ## Prevention
  background-color:: blue
	- ### Health Education
		- Diabetes control importance
	- ### Community Approach
	- ### Screening Programs
		- for diabetes
	- ### Lifestyle Modifications
		- Diet
		- Exercise
		- Smoking cessation
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
		- ADA, NEI guidelines
	- ### Support Groups
		- Diabetes associations
	- ### Counseling Options
		- Low-vision rehabilitation
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
		- Gene therapy, new anti-VEGF agents
	- ### Recent Advances
		- AI based screening tools
- ## Key Literature
  background-color:: blue
	- ETDRS (Early Treatment Diabetic Retinopathy Study)
	- DRCR.net Protocols
- ## Guidelines and Protocols
  background-color:: blue
	- **ADA Standards of Care (2023)**
	- **AAO Preferred Practice Patterns**